The influence of glucose self-monitoring on glycaemic control in patients with diabetes mellitus in Sudan.

OBJECTIVE: To investigate the influence of self-monitoring of glucose on the glycaemic control in Sudanese diabetic subjects. SUBJECTS AND METHODS: A group of 193 consecutive type 2 and type 1 diabetic subjects (95 men, 98 women) were studied. In 104 subjects with type 2 diabetes fasting blood glucose was measured using a glucose meter and blood was obtained for serum glucose measurement in the laboratory. In the remaining 89 diabetic subjects random blood glucose was measured using the same glucose meter and a whole blood sample was drawn for laboratory assessment of HbA1c. Data on self-monitoring and other clinical and personal characteristics were recorded. RESULTS: More than 75% of either type 1 and type 2 diabetic patients never self-monitored blood or urine glucose. In type 2 diabetic subjects self-monitoring of blood or urine glucose was not related to glycaemic control. In type 1 diabetic subjects, however, self-monitoring of blood glucose was significantly associated with better glycaemic control, as assessed by HbA1c (P=0.02) and blood glucose at clinic visits (P< or =0.0001), and similar associations were found for urine glucose self-monitoring (P=0.04 and 0.02) respectively. Neither glycaemic control nor glucose self-monitoring was associated with education level. CONCLUSIONS: Self-monitoring of blood glucose was not found to be associated to better glycaemic control in Sudanese subjects with type 2 diabetes. In contrast, self-monitoring of both blood and urine glucose was significantly associated with glycaemic control in subjects with type 1 diabetes. Self-monitoring of urine glucose could be useful where measurement of blood glucose is not available or affordable.

Glycaemic and insulin responses of six traditional Sudanese carbohydrate-rich meals in subjects with Type 2 diabetes mellitus.

AIMS: The objective of this study was to investigate the influence of six Sudanese traditional carbohydrate-rich meals on glucose and insulin responses and to formulate appropriate dietary guidelines based on glycaemic excursions of traditional foods. METHODS: On six occasions with 1-week intervals, 10 Type 2 diabetic subjects consumed six Sudanese traditional carbohydrate-rich meals. The following meals were tested and also analysed for their composition: wheat gorasa (pancakes), sorghum kisra (flat bread) and sorghum acida (porridge), millet kisra and millet acida and maize acida. Blood samples were collected before and after meal ingestion at 0, 30, 60, 120 and 240 min and analysed for plasma glucose and plasma insulin and incremental areas under the curves (AUC) were calculated. RESULTS: A significant variation in AUC for glucose and insulin responses were found between meals, the over all differences in incremental AUCs between the six meals were significant for both plasma glucose (P = 0.0092) and insulin (P = 0.0001). The 2-h glucose values were 10.5 +/- 2.7 for sorghum flatbread, 9.5 +/- 3.1 for sorghum porridge, 10.3 +/- 3.4 for millet flatbread, 10.6 +/- 3.6 for millet porridge, 11.4 +/- 2.7 for maize porridge and 8.7 +/- 2.4 for the wheat pancakes. The comparison between the AUCs of the meals showed that millet acida (porridge) followed by wheat gorasa (pancakes) displayed significantly lower post-prandial glucose and insulin responses, whereas maize acida induced a higher post-prandial glucose and insulin response. CONCLUSIONS: The comparison of glycaemic and insulin responses to six traditional Sudanese meals show differences of clinical importance, and could form a basis for dietary advice to diabetic subjects in Sudan and countries sharing similar food traditions.

Factors affecting perinatal morbidity and mortality in pregnancies complicated by diabetes mellitus in Sudan.

To investigate the influence of obstetric factors and indices of maternal metabolic control on perinatal morbidity and mortality, 88 diabetic pregnant Sudanese women (type 1, n=38; type 2, n=31; gestational diabetes, n=19) and 50 non-diabetic pregnant control women were studied. The mean fasting blood glucose was 11.1+/-2.8 mmol/l and the mean HbA(1c) at booking interview was 8.8+/-2.1% in the diabetic women. Pregnancy complications such as Caesarean sections, urinary tract infections, pregnancy-induced hypertension and intrauterine foetal death were higher among diabetic compared with control women (P<0.0001) and varied with the type of diabetes. Infants of diabetic mothers had a higher incidence of neonatal complications than those of non-diabetic women (54.4% vs. 20.0%; P<0.0001). Infants without complications and who were born to diabetic mothers had better Apgar scores at 5 min (9.8+/-0.5 vs. 8.9+/-1.6; P<0.01) and lower cord C-peptide when compared to infants with complications (P<0.05). In conclusion, the prevalence of maternal and neonatal complications among Sudanese diabetic women and their infants is high. Maternal hyperglycaemia is an important factor affecting maternal wellbeing and neonatal morbidity and mortality.

Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan.

Differences have been observed in the relationship between leptin and metabolic perturbations in glucose homeostasis. Because no information is available from indigenous African populations with diabetes, the purpose of this study was to investigate the possible associations between leptin and different clinical and biochemical characteristics of a large group of subjects with type 2 diabetes mellitus in Sudan. A total of 104 (45 men and 59 women) consecutive type 2 diabetes patients and 75 control subjects (34 men and 41 women) were studied. The body mass index (BMI), blood glucose, serum insulin, and proinsulin were measured and related to serum leptin concentrations. Leptin was higher in females than in males and correlated significantly to BMI. The main novel finding was that serum leptin was significantly lower in diabetic subjects compared with controls in both females (P =.0001) and males (P =.019), although BMI did not differ between diabetic and nondiabetic subjects. Diabetic subjects treated with sulphonylurea (n = 81) had lower BMI than those treated with diet alone or other hypoglycemic drugs (n = 23) (P =.0017), but there was no difference in leptin levels between the 2 groups after adjustment for BMI (P =.87). In diabetic subjects, serum leptin correlated positively with the homeostatic assessment (HOMA) of both beta-cell function (P =.018) and insulin resistance (P =.038), whereas in control subjects, leptin correlated with insulin resistance (P =.0016), but not with beta-cell function. Diabetic subjects had higher proinsulin levels (P =.0031) and higher proinsulin to insulin ratio (P =.0003) than nondiabetic subjects. In univariate analysis, proinsulin showed a weak correlation to leptin (P =.049). In conclusion, we show in a large cohort of Sudanese subjects with type 2 diabetes that circulating leptin levels are lower in diabetic subjects than in controls of similar age and BMI. The lower serum leptin in diabetic subjects may be a consequence of differences in fat distribution.

Changes in iodine metabolism during late pregnancy and lactation: a longitudinal study among Sudanese women.

OBJECTIVE: To elucidate the persistence, or otherwise, of the pregnancy-related changes in the iodine metabolism and thyroid function in a population residing in an area of mild iodine deficiency in the Sudan. DESIGN: A longitudinal prospective cohort study involving pregnant women who were recruited during their third trimester of pregnancy and were followed up for up to nine months after delivery. SETTING: The study was conducted among Sudanese women residing in the Omdurman area in Khartoum, an area with a total goitre rate of 17.5%. SUBJECTS: Forty-seven pregnant women were recruited during their third trimester of pregnancy. Their mean age and weight were 29+/-4.6 y and 62.4+/-8.7 kg, respectively. Age matched healthy non-pregnant women living in the same area (n=40) served as a control group. METHODS: Serum levels of thyrotropin (TSH), thyroxine (T4), triiodothyronine (T3), thyroglobulin (Tg) and the urinary iodine concentration (UIC) were determined during the third trimester (first occasion), and subsequently at three months (second occasion), six months (third occasion) and nine months after delivery (fourth occasion). Control subjects provided corresponding samples on one occasion. MAIN OUTCOMES MEASURES: UIC, TSH, Tg, FT4 and T3. RESULTS: During the third trimester of pregnancy the median UIC and the free T4 (FT4) were lower than in the control group (P<0. 0001, P<0.0001, respectively), while the median Tg was higher than in the controls (P<0.03). Three months post-partum maximum thyroidal stimulation was evident, with elevated serum levels of TSH and Tg (P<0.0001, P<0.03) and reduced UIC and serum T3 and FT4 (P<0.0004, P<0.0005, P<0.0001), compared with the control group. Nine months post-partum the thyroid function was restored to the pre-pregnancy state, and the median values of TSH, Tg, T3, FT4 and UIC did not differ significantly from those in the control group. CONCLUSIONS: Our study suggests that the reversibility of the pregnancy-induced changes in the iodine status and thyroid function to the pre-pregnancy levels may depend on the iodine status of the mother during and after pregnancy. The thyroidal stress during the first three months of the post-partum period, which is partially due to the iodine loss in the breast milk, justifies further detailed studies to assess the iodine content of the breast milk and the role of breast milk as a vehicle for iodine supply of infants in situations of iodine deficiency. SPONSORSHIP: This study was supported by a grant from the Swedish Agency for Research Co-operation with Developing Countries.

Thyroglobulin in serum as an indicator of iodine status during pregnancy.

Serum thyroglobulin and thyrotropin as well as urinary iodine concentrations were measured in healthy, pregnant Swedish (n=27) and Sudanese (n=21) women and the results compared with those of healthy Swedish (n=14) and Sudanese (n=20) non-pregnant controls. The median thyroglobulin concentrations (and interquartile range) in the Swedish pregnant women for the three trimesters were 15.5 (8-24), 10.5 (7-19) and 18.0 (13-25) microg/L, respectively. The median third trimester concentration was higher than both the first and second trimester concentrations, respectively (p<0.0001, p<0.0001). Compared to the control group, the Swedish pregnant women had a significantly higher median thyroglobulin concentration in the third trimester (p<0.05). Among the Sudanese pregnant women, the median serum thyroglobulin concentrations (and interquartile range) were 27.5 (12-40), 25.0 (15-43) and 30.0 (15-67) microg/L during the first, second and third trimesters, respectively. There were no significant differences between these concentrations. Compared to the control group, the Sudanese pregnant women had a significantly higher median thyroglobulin in the third trimester (p<0.01). The Sudanese pregnant women also showed significantly higher median thyroglobulin concentrations than the Swedish pregnant women in all the three trimesters of pregnancy (p<0.05, p<0.001 and p<0.01, respectively). However, there were no significant differences between the two non-pregnant controls. Among the Swedish pregnant women, 40%, 23% and 30% of the subjects showed serum thyroglobulin concentrations above 20 microg/ L during the first, second and third trimesters of pregnancy, respectively. Corresponding figures for the Sudanese pregnant women were 55%, 61% and 64%, respectively. A significantly negative correlation was shown between serum thyroglobulin and urinary iodine concentrations during the second and third trimesters in the Swedish women (r= -0.8, p=0.01 and r= -0.5, p=0.03, respectively), and in the third trimester in the Sudanese women (r= -0.6, p=0.03). No such correlation was observed between thyrotropin and urinary iodine concentration in either the Swedish or the Sudanese pregnant women. It is concluded that serum thyroglobulin is a more sensitive indicator of iodine deficiency than serum thyrotropin during pregnancy.

Health-related quality of life in insulin-treated diabetic patients in the Sudan.

To determine health-related quality of life (HRQL) in people with insulin-treated diabetes mellitus in Sudan, a total of 89 patients aged 25-55 years and with > or = 5 years diabetes duration was studied. HRQL was measured with a 68-item questionnaire from the Medical Outcomes Study. Late diabetic complications were assessed, and haemoglobin A1c (HbA1c) was measured to assess the metabolic control. Of the patients (m = 36; f = 53), only 13.5%, had good metabolic control ((HbA1c) < 7.5%). These patients rated their HRQL as worse than patients with poor metabolic control ((HbA1c) > 10%). However, the latter were significantly younger, had shorter diabetes duration, and were free from late complications. Overall, 49.4% of the patients had one or more of the late diabetic complications. These patients rated their HRQL significantly lower when compared with patients without complications. Older age and the presence of late diabetic complications were the most important predictors for HRQL. It is concluded that self-rated HRQL in this group of patients is generally low. Improving diabetes knowledge and the metabolic control since early in the course of the disease, will not only retard the development of late complications, but will certainly improve the HRQL of these patients.

A high prevalence of diabetes mellitus and impaired glucose tolerance in the Danagla community in northern Sudan.

The prevalence and associated factors of diabetes mellitus (DM) and impaired glucose tolerance (IGT) were studied in a tribal community with an apparently high diabetes prevalence. A sample of 724 subjects aged > or = 25 years was selected using a multi-stage cluster method and underwent a 75 g oral glucose tolerance test. The crude prevalence of DM and IGT were 8.3% (men 9.9%; women 7.5%) and 7.9% (men 4.1%; women 9.7%), respectively. Age-adjusted prevalence rates, according to the standard population of Segi, were 10.4% (95% CI 7.7-13.2) and 9.8% (95% CI 7.2-12.5) for DM and IGT, respectively. No urban/rural differences were found in the prevalence rates of DM and IGT. New cases (5.1%) were almost twice as common as previously known cases (3.2%). Family history of diabetes, obesity, and advanced age were associated with higher rates of diabetes. The results confirmed that diabetes is common in the Danagla community compared to other communities of northern Sudan. Varying environmental, nutritional, and genetic factors may contribute to this high prevalence. These findings will have profound impact on the health services for this community and the Sudan as a whole.

Classification of newly-onset IDDIM and NIDDIM in subjects aged 25-45 years in Sudan.

OBJECTIVES: To investigate the ability of classifying diabetes mellitus with clinical and biochemical characteristics at diagnosis in 25-45 years old patients. DESIGN: We determined age, body mass index (BMI), ICA, fasting C-peptide and HbA1c at diagnosis, and after 4-27 months follow up, these variables were related to the type of treatment. SETTING: Omdurman Teaching Hospital, Sudan. SUBJECTS: Eighty-six consecutive newly diagnosed diabetic patients, according to WHO criteria, were included. RESULTS: At diagnosis, 27 patients (31.4%) were treated with insulin and 59 (68.6%) with diet and/or oral hypoglycaemic agents (OHA). Insulin-treated patients at diagnosis were younger, had lower BMI and higher HbA1c. In the non-insulin treated group at diagnosis, ICA-negative patients (n = 54) had higher fasting C-peptide (P < 0.05) than ICA-positive. The treatment was changed from insulin to diet and/or OHA in 17 patients, and to insulin in six patients. Patients who discontinued insulin had already at diagnosis higher BMI and higher fasting C-peptide concentration (P < 0.005 and P < 0.05, respectively) than patients remained on insulin. The positive predictive values for insulin treatment of ICA positivity, low fasting C- peptide, and low BMI were 90, 78 and 73%, respectively. The sensitivity, specificity and positive predictive values for these variables in concurrence were, respectively, 85, 92 and 69%. CONCLUSION: The clinical classification of newly- diagnosed young Sudanese patients was satisfactory. With regular follow up and early commencement of appropriate treatment, good glycaemic control is certainly attainable. BMI is potentially valuable for the clinical classification in such patients. ICA and fasting serum C-peptide facilitate the choice of insulin treatment, but cost is a limit to large-scale use of these tests.

A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan.

OBJECTIVE: To study the prevalence of glucose intolerance in adult urban and rural populations in the northern parts of Sudan. RESEARCH DESIGN AND METHODS: A sample of 1,284 subjects aged > or = 25 years was selected using a multistage cluster method and underwent a 75-g oral glucose tolerance test. RESULTS: The crude prevalence was 3.4% (men, 3.5%; women, 3.4%) for diabetes and 2.9% (men, 2.2%; women, 3.3%) for impaired glucose tolerance (IGT). The highest crude prevalence was in the northern parts of Sudan (5.5%) and the lowest in the western desert-like parts (0.9%). Diabetes and IGT rates were not different between the urban and rural populations. New cases (2.2%) were almost twice as prevalent as previously known cases (1.3%). Family history of diabetes, obesity, and advanced age were associated with higher rates of diabetes. CONCLUSION: The results showed a high prevalence of diabetes in the adult population of Sudan, with a wide difference among the different areas. The high ratio of newly discovered to previously known diabetic cases may reflect poor public awareness and medical services. These findings will certainly have far-reaching implications for diabetes care delivery in this country.

Pattern of long-term complications in Sudanese insulin-treated diabetic patients.

The prevalence of long-term micro- and macrovascular complications was studied in 128 (M/F; 62:66) Sudanese insulin-treated diabetic patients aged 15-75 years and with > or = 1 year duration. Patients were recruited from the out-patient clinics of the general hospitals in three States in Sudan. Haemoglobin A1c (HbA1c) was measured to assess the degree of metabolic control. The prevalence of microvascular complications was, retinopathy 43%, nephropathy 22% and neuropathy 37%. For macrovascular complications the prevalence was, cardiovascular disease 28%, peripheral vascular disease 10% and cerebrovascular accidents 5.5%. The overall prevalence of long-term complications was 67%. Patients with these complications were significantly older (P < 0.005), had longer disease duration (P < 0.001), and had higher serum cholesterol and triglyceride concentration (P < 0.001 and P < 0.05, respectively). The glycaemic control was adequate in only 12.5% of the patients, and was not related to the prevalence of complications. Sudanese diabetic patients are more prone to both microvascular and macrovascular complications than previously reported. More attention from the patients and clinicians is required and all efforts should be made to reduce the incidence of these complications.

Glycaemic control of insulin-dependent diabetes mellitus in Sudan: influence of insulin shortage.

Insulin availability and routine diabetes care were cross-sectionally investigated in 122 (M/F; 59/63) insulin-dependent diabetic patients aged 6-60 years with > or = 1 year duration using a structured questionnaire interview followed by a free conversation. Haemoglobin A1c, blood glucose, and serum lipids were measured in the fasting state to assess the metabolic control. Only 12% of the patients had acceptable glycaemic control (HbA1c < 7.5%). Increased age, shorter diabetes duration, and higher body mass index were associated with better metabolic control. Omission or reduction of the insulin dose was experienced by 51% of the patients due to insulin shortage. The interview data consistently indicated that insulin non-availability had induced poor compliance to therapy regimens and lack of motivation for optimum glycaemic control. Due to limited resources, most of the patients received insufficient diabetes care and education, leading to lower rates of clinic attendance (55%), and dietary non-compliance (78.5%). Elevated haemoglobin A1c was associated with higher fasting blood glucose levels (P < 0.001), serum triglycerides (P < 0.05), and urinary glucose (P < 0.001). Measurable fasting C-peptide was observed in 52.5% of the patients and was related to the age at diagnosis, and body mass index (P < 0.001 for both). There is a considerable potential to improve diabetes care and education practice, and if accessibility to insulin is simultaneously facilitated, the glycaemic control in Sudanese diabetic patients will improve.

Hypertensives who cannot get proper antihypertensive treatment.

Hypertension is common in developing countries particularly in Africa and the Caribbean. Antihypertensive treatment has been validated as effective in preventing strokes but often even the cheapest antihypertensive drugs are unavailable. This means that a large number of patients are not receiving the treatment that they need. Action is needed by the International Society of Hypertension, the World Hypertension League, the European and American Societies of Hypertension and the pharmaceutical industry to correct this major shortfall of treatment.